Abstract
We studied the effects of an alginate compound (Gaviscon) on the frequency and the duration of gastroesophageal reflux (GOR) episodes in children. Twenty infants and children with characteristic symptoms of GOR were divided at random into two groups which were given either Gaviscon (ten patients, mean age: 21 months) or a placebo (ten patients, mean age: 35 months). A continuous pH probe monitoring of the lower oesophageal third was performed in all the patients before and after 8 days of treatment. Before the trial, sensitive pH monitoring variables of acid reflux (Euler-Byrne index, percentage of total reflux time per 24 h, mean duration and percentage of reflux time during sleep, total number of reflux episodes per 24 h and number of reflux episodes per 2 h post-cibal periods) were abnormal in all the patients tested. The oesophagram revealed a GOR in 13 of the 20 patients; none of the children who underwent an endoscopy had evidence of oesophagitis. Episodes of regurgitation reported by the parents decreased during Gaviscon therapy while no clinical improvement was noticed in the placebo group. No adverse effects were observed.
After 8 days of treatment with Gaviscon, results of all the pH monitoring variables were significantly (P<0.05) reduced between -35% and -61% of the initial values recorded. In the placebo treated group, the mean values remained little changes (-9.5 to + 8.2% of initial values).
These data suggest that Gaviscon may prove useful in the medical management of GOR in infants and children.
Similar content being viewed by others
Abbreviations
- GOR:
-
gastroesophageal reflux
References
Andrup E, Momme-Jakobsen B (1969) Reflux esophagitis treated with Gaviscon. Acta Chir Scand [Suppl] 369:16–17
Belsey RHR (1972) Gastroesophageal reflux and hiatal hernia. In: Skinner DB, Belsey RHR, Hendrix TR, Zuidema GD (eds). Little, Brown & Co, Boston, p 107
Buts JP, Barudi C, Moulin D, Claus D, Cornu G, Otte JB (1986) Prevalence and treatment of silent gastroesophageal reflux in children with recurrent respiratory disorders. Eur J Pediatr 145:396–400
Euler AR, Byrne WJ (1981) Twenty-four hours esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology 80:957–961
Jolley SG, Johnson QG, Herbst JJ, Pena A, Garnier R (1978) An assessment of gastroesophageal reflux in children by extended pH monitoring of the distal esophagus. Surgery 84:16–22
Sandmark S (1963) Hiatal incompetence. Acta Radiol [Suppl] 219:1–46
Shatzlein MH, Ballantine TUN, Thirunavukkarasu S, Fitzgerald F, Grospeld L (1979) Gastroesephageal reflux in infants and children: diagnosis and management. Arch Surg 114:505–509
Sondheimer JM (1980) Continuous monitoring of distal esophageal pH. A diagnostic test for gastroesephageal reflux in infants. J Pediatr 96:804–807
Stanciu C, Bennett JR (1974) Alginate/antacid in the reduction of gastroesophageal reflux. Lancet II:109–111
Weihrauch TR (1985) Gastro-oesophageal reflux — Pathogenesis and clinical implications. Eur J Pediatr 144:215–218
Weldon AP, Ribonson MJ (1972) Trial of Gaviscon in the treatment of gastroesophageal reflux of infancy. Aust Pediatr J 8:279–281
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buts, J.P., Barudi, C. & Otte, J.B. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr 146, 156–158 (1987). https://doi.org/10.1007/BF02343223
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02343223